Tweet
stv.tv
<img alt="" height="1" width="1" />
HER2 Boosts Recurrence Risk Even for Small Breast Cancers
MedPage Today
Small, early-stage breast cancers that are HER2-positive carry a substantial risk of recurrence and metastasis that may suggest a need for trastuzumab (Herceptin) therapy, researchers said. ...
Drug Could Help Treat Small HER2-Positive Breast TumorsU.S. News & World Report
Even With Very Small Breast Tumors, Studies Find HER2 Status MattersNational Cancer Institute - NCI Cancer Bulletin
Women with breast cancer have low vitamin D levels, scientists discoverNatural News.com (registration)
Newspost Online -The Herald -AME Info
all 47 news articles »
More...